Gene-editing technologies have opened a Pandora's box of possibilities for humanity. These innovations can fundamentally alter human cells and create transformations that range from insignificant to extraordinarily impactful. While such advancements hold immense promise for medical science and
Artis Biosolutions' acquisition of Landmark Bio marks a strategic move designed to bolster cell and gene therapy (CGT) manufacturing capabilities. Landmark Bio, founded by Harvard University, MIT, Fujifilm Diosynth Biotechnologies, Alexandria Real Estate Equities, and Cytiva, has been a key
The field of synthetic biology is experiencing rapid growth, merging principles from biology, engineering, chemistry, physics, and mathematics to unlock new potential in life sciences. At the forefront of this advancement is the University of Delaware (UD), where cutting-edge research is aimed at
The University of South Florida (USF) is undertaking significant expansions in its biomedical engineering program to address its consistent and rapid growth. Established in 2017 with just a single faculty member and courses tailored exclusively for graduate students, the program has seen remarkable
Farmers in Dorset have been advised to reinforce their biosecurity measures following the detection of the avian influenza virus, specifically the H5N1 strain, in a sheep in Yorkshire. The occurrence of this virus in a sheep for the first time serves as a crucial reminder for farms, particularly
African swine fever (ASF) is a highly contagious and deadly viral disease affecting both domesticated and wild pigs. With its widespread prevalence in areas such as Africa, Europe, Asia, and the Caribbean, this disease has significant economic implications. Recent estimates state that if ASF were
